Refractory Cardiac Arrest Research Articles

Early computed tomography after extracorporeal cardiopulmonary resuscitation on in-hospital survival: a retrospective cohort study.

The role of computed tomography (CT) scans after extracorporeal membrane oxygenation (ECMO) implantation in patients with refractory cardiac arrest has not been frequently investigated. Early CT scan findings may have many meaningful findings and contribute significantly to patients' outcome. In this study, we sought to determine whether early CT scans in such patients indirectly improved in-hospital survival. A computerized search of the electronic medical records systems of 2 ECMO centers was conducted. A total of 132 patients who had undergone extracorporeal cardiopulmonary resuscitation (ECPR) between September 2014 and January 2022 were included in the analysis. The patients were divided into 2 groups based on whether they underwent early CT scans (the treatment group) or did not undergo early CT scans (the control group). The findings of early CT scans and in-hospital survival were investigated. A total of 132 patients had undergone ECPR with 71 were male, 61were female and mean age: 48.0±14.3 years. Early CT scans did not improve patient's in-hospital survival [hazard ratio (HR): 0.705; P=0.357]. Overall, a smaller proportion of patients survived in the treatment group (22.5%) than the control group (42.6%; P=0.013). In total, 90 patients were matched in terms of age, initial shockable rhythm, Sequential Organ Failure Assessment (SOFA) score, cardiopulmonary resuscitation (CPR) duration, ECMO duration, percutaneous coronary intervention, and cardiac arrest location. In the matched cohort, fewer patients survived in the treatment group (28.9%) than the control group (37.8%; P=0.371), but the difference was not significant. According to a log-rank test, in-hospital survival did not differ significantly before and after matching (P=0.69, and P=0.63, respectively). Thirteen patients (18.3%) had complications during transportation, among which a drop in blood pressure was the most common. The in-hospital survival rate between treatment and control group was not different, however, early CT scan after ECPR could help clinicians to gain important information to guide clinical practice.

難治性院外心原性心停止に対する初期心電図によるpercutaneous cardiopulmonary support導入時間の検討(Analysis of the percutaneous cardiopulmonary support implementation time for refractory out–of–hospital cardiogenic cardiac arrest by initial electrocardiogram)

要旨【目的】治療抵抗性心停止に対する経皮的心肺補助（以下，PCPS）の転帰良好な因子として，初期心電図がショック適応心リズム（以下，ショックリズム）と心停止（以下，CA）からPCPS開始までの時間（以下，CA to PCPS）が短いことが挙げられる。しかし，近年ではショック非適応心リズム（以下，非ショックリズム）でも転帰良好な症例が報告されており，院外心原性心停止における初期心電図別のCA to PCPSと1か月後の転帰良好について検討した。【対象】これは単施設，後方視的研究であり，2000年1月から2017年3月に院外心原性心停止症例に対してPCPSを導入した219例（平均58歳，男性193例）を対象とした。【結果】ショックリズム群（167例）と非ショックリズム群（52例）において，転帰良好率は31% vs 10%（p＝0.003）であり，CA to PCPSの中央値は44.0分 vs 35.0分（p＝0.014）であった。さらにCA to PCPSを5分ごとに区切り転帰良好率を検討すると，ショックリズム群では36～40分で59%であったが，41～45分では33%まで低下しており，非ショックリズム群では40分以降に転帰良好は存在しなかった。【結語】心停止から40分以内のPCPS導入がより転帰良好になると考えられたが，非ショックリズム群ではさらに短縮する必要がある。

Coronary disease in refractory cardiac arrest undergoing resuscitation with extracorporeal membrane oxygenation.

Because re-establishment of spontaneous circulation (ROSC) in patients with cardiac arrest is frequently not achieved by conventional cardiopulmonary resuscitation (C-CPR), selected patients may undergo resuscitation with extracorporeal membrane oxygenation (E-CPR). We compared angiographic features and percutaneous coronary intervention (PCI) between patients undergoing E-CPR and those with ROSC after C-CPR. Forty-nine consecutive E-CPR patients undergoing immediate coronary angiography admitted between August 2013 and August 2022 were matched to 49 patients with ROSC after C-CPR. Multivessel disease (69.4% vs. 34.7%; P = 0.001), ≥ 50% unprotected left main (ULM) stenosis (18.4% vs. 4.1%; P = 0.025), and ≥1 chronic total occlusion (CTO) (28.6% vs. 10.2%; P = 0.021) were more often documented in E-CPR group. There was no significant differences in the incidence, features, and distribution of acute culprit lesion which was present in >90%. Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) (27.6 vs. 13.4; P = 0.002) and GENSINI (86.2 vs. 46.0; P = 0.001) scores were increased in E-CPR group. Optimal cut-off predicting E-CPR was 19.75 for SYNTAX (sensitivity 74%, specificity 87%) and 60.50 (sensitivity 69%, specificity 75%) for GENSINI score. More lesions were treated (1.3 vs. 1.1 lesions/patient; P = 0.002) and stents implanted (2.0 vs. 1.3/patient; P < 0.001) in E-CPR group. Final TIMI three flow was comparable (88.6% vs. 95.7%; P = 0.196) but residual SYNTAX (13.6 vs. 3.1; P < 0.001) and GENSINI (36.7 vs. 10.9; P < 0.001) scores remained increased in E-CPR group. Extracorporeal membrane oxygenation patients have more multivessel disease, ULM stenosis, and CTO but similar incidence, features, and distribution of acute culprit lesion. Despite more complex PCI, revascularization is less complete.

Current situation, efficacy, and safety of extracorporeal cardiopulmonary resuscitation in China

Current situation, efficacy, and safety of extracorporeal cardiopulmonary resuscitation in China

The Role of Shunt Occlusion During Extracorporeal Life Support.

The current recommendation for systemic to pulmonary artery shunt (SPS) patients requiring extracorporeal life support (ECLS) is to keep the shunt open, maintaining a higher pump flow. The practice in our center is to totally occlude the shunt while on ECLS, and we are presenting the outcome of this strategy. This is a retrospective analysis of patients who underwent SPS for cyanotic congenital heart disease with decreased pulmonary blood flow and required postoperative ECLS between January 2016 and December 2020. ECLS indication was excessive pulmonary blood flow, leading to either refractory low cardiac output syndrome (LCOS) or cardiac arrest. All patients had their shunts totally occluded soon after ECLS establishment. Of the 27 SPS patients who needed postoperative ECLS (13 refractory LCOS, 14 extracorporeal cardiopulmonary resuscitation), wherein the strategy of occluding the shunt on ECLS initiation was followed, 16 (59.3 %) survived ECLS weaning and eight (29.6%) survived to discharge. Increased flow to maintain systemic circulation for a SPS patient while on ECLS is an accepted strategy, but it should not be applied universally. A large subset of SPS patients, who require ECLS either due to cardiac arrest or refractory LCOS due to excessive pulmonary flow, might benefit from complete occlusion of the shunt soon after commencement of ECLS, especially in cases with frank pulmonary edema or haemorrhage in the pre-ECLS period. A prospective randomized trial could be ethically justified for the subset of patients receiving ECLS for the indication of excessive pulmonary blood flow.

Multiparameters associated to successful weaning from VA ECMO in adult patients with cardiogenic shock or cardiac arrest: Systematic review and meta-analysis.

Venoarterial extracorporeal membrane oxygenation (VA ECMO) is a form of temporary mechanical circulatory support and simultaneous extracorporeal gas exchange for acute cardiorespiratory failure, including refractory cardiogenic shock (CS) and cardiac arrest (CA). Few studies have assessed predictors of successful weaning (SW) from VA ECMO. This systematic review and meta-analysis aimed to identify a multiparameter strategy associated with SW from VA ECMO. PubMed and the Cochrane Library and the International Clinical Trials Registry Platform were searched. Studies reporting adult patients with CS or CA treated with VA ECMO published from the year 2000 onwards were included. Primary outcomes were hemodynamic, laboratory, and echocardiography parameters associated with a VA ECMO SW. A total of 11 studies (n=653) were included in this review. Pooled VA ECMO SW was 45% (95%CI: 39-50%, I2 7%) and in-hospital mortality rate was 46.6% (95%CI: 33-60%; I2 36%). In the SW group, pulse pressure [MD 12.7 (95%CI: 7.3-18) I2 = 0%] and mean blood pressure [MD 20.15 (95%CI: 13.8-26.4 I2 = 0) were higher. They also had lower values of creatinine [MD -0.59 (95%CI: -0.9 to -0.2) I2 = 7%], lactate [MD -3.1 (95%CI: -5.4 to -0.7) I2 = 89%], and creatine kinase [-2779.5 (95%CI: -5387 to -171) I2 = 38%]. And higher left and right ventricular ejection fraction, MD 17.9% (95%CI: -0.2-36.2) I2 = 91%, and MD 15.9% (95%CI 11.9-20) I2 = 0%, respectively. Different hemodynamic, laboratory, and echocardiographic parameters were associated with successful device removal. This systematic review demonstrated the relationship of multiparametric assessment on VA ECMO SW.

Prehospital Extracorporeal Cardiopulmonary Resuscitation for Out-of-Hospital Cardiac Arrest: A Systematic Review and Meta-Analysis

To evaluate the available published evidence of the effects of extracorporeal cardiopulmonary resuscitation (ECPR) in the prehospital setting on clinical outcomes in patients with out-of-hospital cardiac arrest. A systematic review and meta-analysis designed according to the Preferred Reporting Items for Systematic Reviews an Meta-Analyses guidelines. In the prehospital setting. All randomized control trials (RCTs) and observational trials using pre-hospital ECPR in adult patients (>17 years). Prehospital ECPR. The study authors searched Medline, Embase, and PUBMED for all RCTs and observational trials. The studies were assessed for clinical, methodologic, and statistical heterogeneity. The primary outcome was survival at hospital discharge. The study outcomes were aggregated using random-effects meta-analysis of means or proportions as appropriate. The Grading of Recommendations Assessment, Development and Evaluation methodology was used to assess the quality of evidence. Four studies were included, with a total of 222 patients receiving prehospital ECPR (mean age=51 years [95% CI 44-57], 81% of patients were male (CI 74-87), and 60% patients had a cardiac cause for their arrest (95% CI 43-76). Overall survival at discharge was 23.4% (95% CI 15.5-33.7; I2=62%). The pooled low-flow time was 61.1 minutes (95% CI 45.2-77.0; I2=97%). The quality of evidence was assessed to be low, and the overall risk of bias was assessed to be serious, with confounding being the primary source of bias. No definitive conclusions can be made as to the efficacy of prehospital ECPR in refractory cardiac arrest. Higher quality evidence is required.

Anti-thrombotic Therapy With Cangrelor and Bivalirudin in Venoarterial Extracorporeal Membrane Oxygenation Patients Undergoing Percutaneous Coronary Intervention: A Single-Center Experience.

VA-ECMO is commonly used for patients in cardiogenic shock (CS) or refractory cardiac arrest (CA) undergoing PCI for ACS. In this setting at high risk of both thrombotic and hemorrhagic complications, optimal anti-thrombotic therapy remains ill-defined. We hypothesized that an anti-thrombotic therapy comprising a parenteral anticoagulant (bivalirudin) and a parenteral anti-platelet agent (cangrelor) may prove safe and effective in this scenario. From November 2019 to December 2021, 14 patients received at least one dose of cangrelor (starting dose: 0.125 μg/kg/min) plus bivalirudin, without background aspirin, in the context of PCI and VA-ECMO for ACS-related CS/CA, and were included in this study. Efficacy endpoint was occurrence of thrombotic events and safety endpoint was major bleeding occurrence. Median age was 58 years. The majority (64%) presented with refractory CA. A thrombotic event occurred in 14%, while major bleeding occurred in 21% patients. One patient experienced arterial thrombosis after VA-ECMO arterial cannula removal, another experienced ischemic cerebellar stroke without functional sequelae. Bleeding events were: 29% BARC 3a, 14% BARC 3b, and 7% BARC 5b. Overall in-hospital mortality was 50%. Cangrelor was continued for 5 (4-10) days; temporary discontinuation was necessary in 36%, either for VA-ECMO cannula removal or for bleeding events. A low dose of cangrelor, associated with standard-intensity anticoagulation with bivalirudin was a feasible anti-thrombotic strategy in patients undergoing PCI during VA-ECMO support for ACS-related CS/CA. Bleeding events rates outweighed thrombotic events rates in this critically-ill population, although the observed rates were lowest among available studies.

Extracorporeal cardiopulmonary resuscitation in adults and children: A review of literature, published guidelines and pediatric single-center program building experience.

Extracorporeal cardiopulmonary resuscitation (ECPR) is an adjunct supportive therapy to conventional cardiopulmonary resuscitation (CCPR) employing veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the setting of refractory cardiac arrest. Its use has seen a significant increase in the past decade, providing hope for good functional recovery to patients with cardiac arrest refractory to conventional resuscitation maneuvers. This review paper aims to summarize key findings from the ECPR literature available to date as well as the recommendations for ECPR set forth by leading national and international resuscitation societies. Additionally, we describe the successful pediatric ECPR program at Texas Children's Hospital, highlighting the logistical, technical and educational features of the program.

Feasibility and performance of a combined extracorporeal assisted cardiac resuscitation and an organ donation program after uncontrolled cardiocirculatory death (Maastricht II).

Approximately 500.000 people in Europe sustain cardiac arrest (CA) every year, being myocardial infarction the main etiology. Interest has been raised in a new approach to refractory cardiac arrest (rCA) using extra-corporeal oxygenation (ECMO). In settings where it can be rapidly implemented, ECMO assisted resuscitation (ECPR) may be considered. Additionally, donation after circulatory death, which seeks to obtain solid organs donation from patients suffering rCA, has increased its role effectively increasing the pool of donors. Combined programs with integration of ECPR and uncontrolled donation after circulatory determination of death (uDCDD) are worldwide limited and experience integrating these two techniques is lacking. We report a 24months experience of ECPR and uDCDD kidney transplantation based on a management protocol in a university teaching hospital in the urban area of Lisbon. Over a period of 24months, 58 patients were admitted to our ICU with rCA, 6 (10%) in the ECPR program and 52 (90%) in the uDCDD. Seventy-eight percent of patients were male, with an average age of 49year-old. CA was witnessed in 83% of cases and initial rhythm was ventricular fibrillation in 20 cases (35%). 13 (25%) patients were effective organ donors. Refusal for effective donation was mainly due to prior comorbidities. The development of an integrated program for ECPR and uDCDD is feasible and requires a well-established and efficient activation program. In an era of significant organ shortage, it provides a viable option for increasing the organ donation pool, with promising results.

Abstract 272: Withholding/withdrawal Of Life-sustaining Therapy Decision For Out-of-hospital Cardiac Arrest Patients With Extracorporeal Cardiopulmonary Resuscitation Is Commonly Influenced By Perceived Unfavorable Neurological Prognosis At Early Admission

Introduction: Extracorporeal cardiopulmonary resuscitation (ECPR) in patients with refractory cardiac arrest is rapidly becoming a common strategy worldwide. Despite its benefits, ECPR is still associated with significant morbidity, including a high prevalence of brain injury/ischemia. ECPR raises a variety of ethical concerns when discontinuing treatment, however, there is little information about the withholding/withdrawal of life-sustaining therapy (WLST) decision for out-of-hospital cardiac arrest (OHCA) patients after ECPR. Hypothesis: We tested whether early WLST is obtained in OHCA patients with ECPR, and examined the differences in patient characteristics between ECPR/OHCA patients with or without WLST. Methods: We conducted a post-hoc analysis of data from the SAVE-J II study (a retrospective, multicenter study of ECPR in Japan from 2013 to 2018). Inclusion criteria: Patients who underwent ECPR for OHCA with internal causes. Exclusion criteria: death in the emergency department (without admission), diagnosis of brain hemorrhage/acute aortic dissection as cause of arrest. The dates and reasons for the decisions were recorded. Further, differences between ECPR/OHCA patients with or without WLST were compared using univariable analysis. Results: We included 1651 patients in the analysis; WLST was decided in 506 (31%) of patients at a median of two days. WLST was decided within three days in 291 patients (18%). Reasons for WLST decision were perceived unfavorable neurological prognosis (285/477 [59.7%]), perceived unfavorable cardiac/pulmonary prognosis (99/477 [20.7%]), inability to maintain extracorporeal cardiopulmonary support (71/477 [14.8%]), complications (12/477 [2.5%]), and others (10/477 [2%]). Older age (WLST vs. non-WLST, median [IQR]: 63 [51-71] vs. 61 [49-68], p=0.001) and daily hemodialysis before the collapse (7.7% vs. 4.7%, p=0.015) were factors in the WLST decision. Patients with WLST had higher 1 month mortality (505/506 [99.8%] vs. 889/1145 [77.6%], p&lt;0.001). Conclusion: About one-third of ECPR/OHCA patients had WLST decided at a median of two days, mainly for perceived unfavorable neurological prognoses reason. Decisions and neurological assessments for ECPR/OHCA patients need further analysis.

Abstract 13900: Combined Use of Venoarterial Extracorporeal Menbrane Oxygenation and Impella Improves the Outcome in Patients With Cardiogenic Shock

Introduction: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) provides benefit to patients in refractory cardiac arrest and cardiogenic shock. However, VA-ECMO elevates LV afterload and causes pulmonary edema and LV distension. Additional IABP support has been recommended in Japan to reduce LV afterload. Alternatively, transcatheter left ventricular assist device, Impella has been recently introduced. However, it remains to be evaluated if there is clinical benefit of concomitant use of VA-ECMO and Impella (ECPELLA). Methods: Aim of this single-site cohort study is to assess the effects of ECPELLA as compared with ECMO with IABP in patients who were managed with VA-ECMO due to refractory cardiogenic shock including cardiac arrest. Results: We retrospectively reviewed 253 consecutive patients, who received VA-ECMO from January 2012 to May 2022 in our institute. Among them, 67 patients who were managed with VA-ECMO alone were excluded. Patients were divided into two groups, ECEPLLA (n=68) and ECMO with IABP (n=118). We applied propensity score analysis with 1:1 score matching using dependent variables of age, the rate of sex, acute coronary syndrome, out-of-hospital and in-hospital cardiac arrest, and extracorporeal cardio-pulmonary resuscitation. We assessed 30-day survival rate, hemodynamic data, and safety profiles including acute kidney injury, blood transfusion and embolic cerebral infarction. Results: Following propensity score matching, 60 ECPELLA and 60 ECMO with IABP patients were included for analysis. The 30-day survival was significantly higher with ECPELLA group compared with ECMO with IABP group (ECPELLA: 48% vs. ECMO with IABP: 28%, p= 0.01, log-rank test). There were no statistical differences in ECMO weaning rate and safety profiles between treatment groups. Conclusions: ECPELLA may be associated with improved 30-day survival in patients with refractory cardiac shock including cardiac arrest.

Abstract 271: The Time Dependence Of The Effect Of Extracorporeal Cpr For Out-of-hospital Cardiac Arrest Patients

Background: Extracorporeal cardiopulmonary resuscitation (ECPR) has been considered as a rescue therapy for refractory cardiac arrest patients. However, little is known about who is refractory to conventional CPR and when to judge the initiation of ECPR. Method: We performed a secondary analysis of the nationwide hospital-based prospective observational study (The JAAM-OHCA registry) in Japan. This study included adult OHCA patients aged ≥18 years who had an initial shockable rhythm between June, 2014 and December, 2019. We classified the included patients into the ECPR group or the conventional CPR group based on whether to receive ECPR or not. Low flow duration (LFD) was defined as the time from call to the initiation of ECPR or to the time of return of spontaneous circulation or termination of resuscitation. The primary outcome was 1-month survival with favorable neurological outcomes defined by cerebral performance category 1 or 2. We visually described the nonlinear relationship between LFD and the predictive probability of favorable neurological outcome using a restricted cubic spline by each group. Results: Of 57,754 patients registered in the JAAM-OHCA registry, 3807 patients were included in analyses (ECPR group, n = 865 and Conventional CPR group, n = 2942). In both groups, shorter LFD was associated with favorable neurological outcome. For first 30 minutes, the overall proportion of favorable neurological was higher in the Conventional CPR group, but due to the rapid decrease in Conventional CPR, it dropped down to almost the same probability before 20 min as that of shortest LFD around 25 min in the ECPR group. After that, the probability of favorable neurological outcome was constantly higher in the ECPR group. Conclusion: The judgement of refractory cardiac arrests and decision for ECPR should be delivered before 20 min from call to maximize the probability of favorable neurological outcome for those with an initial shockable rhythm.

Abstract 07: Percutaneous Ventricular Assist Devices In Refractory Cardiac Arrest: The Role Of Chest Compressions

Background: Recent studies describe an emerging role for percutaneous ventricular assist devices (pVADs, Impella CP®, Abiomed) as rescue therapy for refractory cardiac arrest (CA). We hypothesized that continuing mechanical chest compressions (mCPR) after initiation of pVAD would improve hemodynamics by decompressing the right ventricle and augmenting pulmonary blood flow and left ventricular filling. We performed a pilot study to test this hypothesis using a swine model of prolonged cardiac arrest. Methods: Eight Yorkshire swine, anesthetized, intubated and instrumented for hemodynamic monitoring, were subjected to untreated ventricular fibrillation for 5.75 (SD 2.90) minutes followed by mCPR for a mean of 20.00 (SD 5.0) minutes before initiation of pVAD (Table 1). After pVAD initiation mCPR was stopped (n=4) or continued (n=4). Defibrillation was attempted 4, 8 and 12 minutes after initiating pVAD circulatory support, except for the first pilot animal where it was attempted at 2 minutes. The animals that achieved return of spontaneous heartbeat&amp;nbsp;(ROSHB) were maintained on pVAD support for four additional hours. Results: There was no difference in the rate of ROSHB between groups (Table 1). The pVAD + mCPR group had significantly higher pVAD flow prior to ROSHB at four- and twelve-minutes after pVAD initiation, and significantly higher end tidal CO 2 (PetCO 2 ) at four- and eight-minutes after pVAD initiation, when compared with the pVAD alone group (Table 1). There was a trend toward higher carotid artery flow prior to ROSHB in the pVAD + mCPR group compared with the pVAD alone group after pVAD initiation, but the difference&amp;nbsp;was not statistically significant (Table 1). Conclusion: The addition of mCPR to pVAD support during cardiac arrest may generate higher pVAD flow and cardiac output prior to ROSHB compared to pVAD alone. Further studies are needed to determine if this approach improves other hemodynamic parameters or outcomes after prolonged cardiac arrest.

Abstract 279: Ecpr, A New Source Of Organs

Purpose: The scarcity of renal grafts is a major public health problem. New strategies are sought to overcome the problem of organ shortage. Organ donation after brain death is a major source of renal grafts. In our center, extracorporeal cardiopulmonary resuscitation (ECPR) is used as a 2nd line of treatment for refractory cardiac arrest. Despite this treatment, some patients present brain death and become eligible to organ donation. To this day, information is scarce on the long-term outcome of renal grafts from these patients. The objective of this study was to evaluate this outcome. Methods: We conducted a monocentric retrospective observational study between 2011 and 2017. The study was validated by the local ethics committee. We included patients who were eligible to organ donation after diagnosis of brain death and from whom at least one organ graft was procured and transplanted. Among these patients we compared those who were treated by ECPR for refractory cardiac arrest (ECPR group) and those who were not (control group). Results: During the study period, 45 patients were included, respectively 23 and 22 in the control and ECPR groups. Patients from the ECPR group were younger with less comorbidities (respectively 41+/-13 vs 63+/-19 years in the ECPR and control groups, p&lt;0,044). However, they were more severe during their ICU stay, as shown by their SAPS II score which was significantly higher (80+/-13 vs 61+/-15 in the ECPR and control groups respectively, p&lt;0,001). A total of 68 renal grafts were procured, transplanted, and studied (34 in each group). There was no difference between the 2 groups in terms of graft survival at 1 year (94.1 vs 82.4% in the ECPR and control group respectively, p=0,52). Discussion-Conclusion: Our study outlines that kidneys harvested from patients treated with ECPR have similar long-term outcome to organs retrieved from patients developing brain death without ECPR. Younger age and absence of comorbidities seem to compensate patient severity after cardiac arrest. One could hypothesize on a protective effect of ECPR on kidney function due to continuous blood flow delivered in the descending aorta. With the increase of ECPR cases, this strategy could be an increasing source of organs to address the issue of organ shortage.

Abstract 282: Extracorporeal Resuscitation For Out-of-Hospital Cardiac Arrest Patients: Analysis By Time-Dependent Propensity Score Matching Using Nationwide Database In Japan

Background: Extracorporeal cardiopulmonary resuscitation (ECPR) has been focused as a rescue therapy for the refractory cardiac arrest patients; however, little is known about the effect of ECPR on survival. The aim of this study is to evaluate the association between ECPR and the survival among the out-of-hospital cardiac arrest patients. Method: This was the secondary analysis of JAAM-OHCA registry which is a nationwide multicenter prospective study collecting the data of out-of-hospital cardiac arrest patients from July 2012 to December 2019. The study participant were adult (≥18 years) cardiac arrest patients due to internal medical cause. Initial cardiac rhythm was stratified as initial shockable and non-shockable rhythm. Patients received ECPR were sequentially matched with the patients who had not yet received within the same minutes (control) based on the time-dependent propensity scores calculated from the patient characteristics to eliminate the resuscitation time bias. Odds ratio with 95% confidence interval (CI) of ECPR for the 30-day survival were calculated by conditional logistic model. Results: Of 57,754 patients in the JAAM-OHCA registry, 1,826 matched cohort with initial shockable rhythm (913 treated with ECPR and 913 control) and 740 matched cohort with initial non-shockable rhythm (370 treated with ECPR and 370 control) were eligible for analysis. Their characteristics between with ECPR and control were well balanced. In the matched cohort with initial shockable rhythm, 30-day survival was 24.6% (225/913) in the patients with ECPR and 16.3% (149/913) in the control. In the matched cohort with initial non-shockable rhythm, 30-day survival was 11.9% (44/370) in the patients with ECPR and 2.4% (9/370) in the control. Odds ratio of with ECPR for 30-day survival was 1.76 [95%CI: 1.38-2.25] in shockable rhythm and 5.37 [95%CI: 2.53- 11.43] in non-shockable rhythm, referred to the control. Conclusion: This time-dependent propensity score sequential matching analysis suggested that ECPR was associated with the 30-day survival outcomes among the out-of-hospital cardiac arrest patients with both initial shockable and non-shockable rhythms.

Abstract 201: Resuscitation And Hemodynamic Impact Of Aortic Balloon Occlusion And Percutaneous Left Ventricular Assist Device In A Swine Model Of Cardiac Arrest

Introduction: Invasive mechanical support by percutaneous left ventricular assist device (pL-VAD) and percutaneous balloon occlusion of the aorta (pAO) during CPR have recently emerged as feasible resuscitation strategies for refractory cardiac arrest. It is unknown if combining pL-VAD and pAO has additive or synergist benefits during CPR. Hypothesis: Combined pAO and pL-VAD during CPR will significantly enhance coronary and cerebral perfusion pressure (CoPP, CePP), return of spontaneous heartbeat (ROSHB) rate, and post-ROSHB cardiac function compared to either therapy alone after prolonged cardiac arrest in a swine model. Methods: Nineteen swine 52 (3.9) kg; (9 male) were utilized. A pL-VAD (Impella CP®) and a balloon catheter were inserted through the femoral arteries under general anesthesia. Ventricular fibrillation was induced and left untreated for 8 minutes followed by 16 minutes of mechanical CPR (mCPR). Animals were randomized to 3 treatment groups A) pL-VAD (n=6), B) pL-VAD+pAO (n=6), and C) pAO (n=7). Treatment was initiated 24 minutes after arrest. mCPR was continued during treatment. Defibrillation was attempted 3 times starting at minute 28 and then every 4 minutes. Hemodynamics, cardiac function, and blood gases were monitored for 4 hours after ROSHB. Results: Following the intervention, CoPP for Group B increased by a mean (SD) of 26 (15) mmHg which is significantly different from both groups A and C, 3.6 (12) and 7.5 (6.3) mmHg ( p =0.007). CePP increased by 2 (11.5), 18.5 (18.6), and 8.3 (6.8) mmHg for groups A, B, and C with no significant differences ( p =0.06). The rate of ROSHB was 67% (4 of 6), 83% (5 of 6), and 100% (7 of 7) for groups A, B, and C ( p &gt;0.05). All groups exhibited similar levels of post-ROSHB recovery including blood pressure, venous oxygen saturation, cardiac output, ejection fraction, and lactate clearance. Total ionotropic and vasopressor support (epinephrine and norepinephrine) was 56 (25), 50 (5), and 81 (90) mcg/Kg in groups A, B, and C ( p =0.66). Conclusion: Combined pAO and pL-VAD resulted in greater improvement of CPR hemodynamics compared to either intervention alone in this model of prolonged cardiac arrest. However, it remains unclear if this translates into better recovery of cardiovascular and neurological function.

Long-Term Survival and Quality of Life in Non-Surgical Adult Patients Supported with Veno-Arterial Extracorporeal Oxygenation.

The use of veno-arterial extracorporeal membrane oxygenation (VA ECMO) for hemodynamic support is on the rise. Not much is known about the impact of extracorporeal membrane oxygenation (ECMO) and its complications on long-term survival and quality of life. In this single-center, cross-sectional study, we evaluated the survival and quality of life in patients treated with VA ECMO between May 2009 and July 2019. Follow-up was conducted between November 2019 and January 2020. Overall, 118 patients were evaluated in this study. Of the 37 patients who were alive at hospital discharge, 32 answered the EuroQol-5 dimensional-5-level questionnaire (EQ-5D-5L). For patients discharged alive from the hospital, mean survival was 8.1 years, 8.4 years for cardiogenic shock, and 5.0 years for patients with refractory cardiac arrest. EQ-5D-5L index value of ECMO survivors was not significantly different from the general age-matched population. Neurologic complications and major bleeding during index hospitalization limit long-term quality of life. Patients treated with VA ECMO have high in-hospital mortality, with extracorporeal membrane oxygenation cardio-pulmonary resuscitation patients being at higher risk of early death. However, once discharged from the hospital, most patients remain alive with a reasonable quality of life.

Role of the emergency department in implementing an extracorporeal membrane oxygenation cardiopulmonary resuscitation.

The Royal Brisbane and Women's Hospital has introduced an extracorporeal membrane oxygenation (ECMO) cardiopulmonary resuscitation (E-CPR) service with collaboration between ED and ICU teams for refractory cardiac arrest patients. E-CPR is potentially beneficial to patients who do not gain return of spontaneous circulation after conventional advanced cardiac life support treatments, provided specific demographic and biochemical inclusion criteria are met. A joint ICU and ED decision is reached to commence ECMO flow. We discuss our rationale to use the ED and the emergency physician role in leading the multidisciplinary team, with ICU leading the cannulation team. The development of ED processes and the increased availability of this intervention can significantly impact the survivability of refractory cardiac arrest with good neurological outcomes.

A Successful Case of Cardiac Arrest due to Acute Myocarditis with COVID-19: 120 Minutes on Manual Cardiopulmonary Resuscitation then Veno-Arterial Extracorporeal Membrane Oxygenation

Acute myocarditis is one of the common complications of coronavirus disease 2019 (COVID-19) with a relatively high case fatality. Here reported is a fulminant case of a 42-year-old previously healthy woman with cardiogenic shock and refractory cardiac arrest due to COVID-19-induced myocarditis who received veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) after 120 minutes of cardiopulmonary resuscitation (CPR). This is the first adult case of cardiac arrest due to COVID-19-induced myocarditis supported by ECMO that fully recovered with normal neurological functions. The success of the treatment course with full recovery emphasized the potential role of ECMO in treating these patients.